funding for travel or speaker honoraria : ( 1 ) istanbul ms days , novartis pharmaceuticals , speaker honoraria payment to mayo clinic . no personal compensation . ( 2 ) invited professor program , biogen - boston , speaker honoraria payment to mayo clinic . no personal compensation . other activities : grant review for the national multiple sclerosis society . research support , commercial entities : dr . orhun h. kantarci receives research support from the european regional development fund ( fnusaicrc cz.1.05/1.1.00/02.0123 ) , the national multiple sclerosis society , and has given a scientific presentation at a meeting supported by teva pharmaceuticals but has received no personal fees or personal compensation for this activity ( all compensation for consulting activities paid directly to mayo clinic ) nor has spoken about the specific medications involving this company . kejal kantarci ( spouse ) serves on the data safety monitoring board of takeda global research and development center , inc . , and the data monitoring boards of pfizer inc . and janssen alzheimer immunotherapy and is funded by the nih ( r01 ag040042 [ pi ] , r21 ns066147 [ pi ] , p50 ag44170/project 2 [ pi ] , p50 ag16574/project 1 [ pi ] , r01 ag11378 [ co - i ] , u19 ag10483 [ co - i ] u01 ag042791 [ co - i ] ) and minnesota partnership for biotechnology and medical genomics ( po03590201 [ pi ] ) . kejal kantarci serves on the data safety monitoring board of takeda global research and development center , inc . , and the data monitoring boards of pfizer inc . and janssen alzheimer immunotherapy and is funded by the nih ( r01 ag040042 [ pi ] , r21 ns066147 [ pi ] , p50 ag44170/project 2 [ pi ] , p50 ag16574/project 1 [ pi ] , r01 ag11378 [ co - i ] , u19 ag10483 [ co - i ] u01 ag042791 [ co - i ] ) and minnesota partnership for biotechnology and medical genomics ( po03590201 [ pi ] ) kejal kantarci serves on the data safety monitoring board of takeda global research and development center , inc . janssen alzheimer immunotherapy and is funded by the nih ( r01 ag040042 [ pi ] , r21 ns066147 [ pi ] , p50 ag44170/project 2 [ pi ] , p50 ag16574/project 1 [ pi ] , r01 ag11378 [ co - i ] , u19 ag10483 [ co - i ] u01 ag042791 [ co - i ] ) and minnesota partnership for biotechnology and medical genomics ( po03590201 [ pi ] ) . research support , foundations and societies : 20062009 multiple sclerosis society for support in multiple sclerosis research unrelated to this publication ; 20082009 mayo foundation cr20 award for support in multiple sclerosis research unrelated to this publication ; 20092011 hilton foundation support in multiple sclerosis research unrelated to this publication .